Delays in drug approvals mean Irish heart and cancer patients lose out on new treatment
A new report from the Irish Pharmaceutical Healthcare Association (IPHA) says that Irish patients are among the last in Europe to get access to new medicines, meaning they could be missing out...
Read moreDetails









